CTRI/2020/06/025573招募中3 期
Phase III trial of hypo-fractionated accelerated intensity modulated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed Glioblastoma (HYART-GBM) - HYART-GBM
AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18 - 65 years
- •Patients of either sex will be included
- •Karnofsky performance score 70 and above
- •Biopsy proven Glioblastoma (WHO grade IV)
- •Baseline investigations [LFT, RFT, complete blood count] should be within normal limits Hemoglobin >10gm/dl, Platelet >100000, TLC-4000-11000
- •No history of prior anti-cancer treatment with radiotherapy, chemotherapy or surgery
- •The patient must sign an informed consent before entry into the study
排除标准
- •Age >65 years and <18 years
- •Previous history of nuero-surgery or radiotherapy
- •Recurrent or metastatic disease
- •Patients with significant co-morbid condition
- •History of previous malignancy
- •Performance score below 70
- •Unresectable disease
- •Not compliant for regular follow up
研究者
相似试验
已完成
不适用
Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancerProstate cancerJPRN-UMIN000022570Kitasato university55
招募中
2 期
imited fraction radiation in anaplastic astrocytomaCTRI/2021/08/035719AIIMS
招募中
2 期
Hypofractionted radiation for Anaplastic AstrocytomaCTRI/2021/11/037820AIIMS
已完成
不适用
Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancerlocalized prostate cancerJPRN-UMIN000038279agoya City University West Medical Center300
已完成
3 期
A randomised phase III trial of focal fractionated conformal stereotactic boost following conventional radiotherapy of high grade gliomasBrainCancerISRCTN37123666Medical Research Council (MRC) (UK)605